These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 1365418
1. The phosphorylation state of DARPP-32, a third messenger for dopamine, is regulated by in vivo pharmacological treatments. Di Luca M, Cimino M, Cattabeni F. Neurochem Int; 1992 Mar; 20 Suppl():165S-170S. PubMed ID: 1365418 [Abstract] [Full Text] [Related]
2. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. Girault JA, Hemmings HC, Williams KR, Nairn AC, Greengard P. J Biol Chem; 1989 Dec 25; 264(36):21748-59. PubMed ID: 2557337 [Abstract] [Full Text] [Related]
3. D1-Receptor, DARPP-32, and PP-1 in the primate corpus luteum and luteinized granulosa cells: evidence for phosphorylation of DARPP-32 by dopamine and human chorionic gonadotropin. Mayerhofer A, Fritz S, Grünert R, Sanders SL, Duffy DM, Ojeda SR, Stouffer RL. J Clin Endocrinol Metab; 2000 Dec 25; 85(12):4750-7. PubMed ID: 11134138 [Abstract] [Full Text] [Related]
4. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G. Proc Natl Acad Sci U S A; 2000 Feb 15; 97(4):1856-60. PubMed ID: 10677546 [Abstract] [Full Text] [Related]
5. DARPP-32: an integrator of neurotransmission. Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. Annu Rev Pharmacol Toxicol; 2004 Feb 15; 44():269-96. PubMed ID: 14744247 [Abstract] [Full Text] [Related]
6. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase I in vitro and in vivo. Desdouits F, Cohen D, Nairn AC, Greengard P, Girault JA. J Biol Chem; 1995 Apr 14; 270(15):8772-8. PubMed ID: 7721783 [Abstract] [Full Text] [Related]
7. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G. Neuroscience; 1998 May 14; 84(1):223-8. PubMed ID: 9522376 [Abstract] [Full Text] [Related]
8. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor. Edwards S, Simmons DL, Galindo DG, Doherty JM, Scott AM, Hughes PD, Wilcox RE. Alcohol Clin Exp Res; 2002 Feb 14; 26(2):173-80. PubMed ID: 11964556 [Abstract] [Full Text] [Related]
9. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern. Rauggi R, Scheggi S, Cassanelli A, De Montis MG, Tagliamonte A, Gambarana C. J Neurochem; 2005 Feb 14; 92(4):867-77. PubMed ID: 15686489 [Abstract] [Full Text] [Related]
10. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. Desdouits F, Siciliano JC, Greengard P, Girault JA. Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2682-5. PubMed ID: 7708705 [Abstract] [Full Text] [Related]
11. Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors. Matsuyama S, Higashi H, Maeda H, Greengard P, Nishi A. J Neurochem; 2002 Apr 28; 81(2):325-34. PubMed ID: 12064480 [Abstract] [Full Text] [Related]
12. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC, Nairn AC, Greengard P. Nature; 1999 Dec 09; 402(6762):669-71. PubMed ID: 10604473 [Abstract] [Full Text] [Related]
13. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G. Neuroscience; 1999 Dec 09; 88(4):1005-8. PubMed ID: 10336115 [Abstract] [Full Text] [Related]
14. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Hemmings HC, Greengard P, Tung HY, Cohen P. Nature; 1999 Dec 09; 310(5977):503-5. PubMed ID: 6087160 [Abstract] [Full Text] [Related]
15. Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation. Nishi A, Snyder GL, Fienberg AA, Fisone G, Aperia A, Nairn AC, Greengard P. Eur J Neurosci; 1999 Jul 09; 11(7):2589-92. PubMed ID: 10383649 [Abstract] [Full Text] [Related]
16. In vivo modulation of striatal phosphoproteins by dopaminergic agents. Di Luca M, Cimino M, Abbracchio MP, Cattabeni F. Eur J Pharmacol; 1989 Oct 17; 172(4-5):321-8. PubMed ID: 2573537 [Abstract] [Full Text] [Related]
17. Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling. Matsuyama S, Fukui R, Higashi H, Nishi A. Eur J Neurosci; 2003 Sep 17; 18(5):1247-53. PubMed ID: 12956723 [Abstract] [Full Text] [Related]
18. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. Snyder GL, Girault JA, Chen JY, Czernik AJ, Kebabian JW, Nathanson JA, Greengard P. J Neurosci; 1992 Aug 17; 12(8):3071-83. PubMed ID: 1494946 [Abstract] [Full Text] [Related]
19. The role of DARPP-32 in the actions of drugs of abuse. Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. Neuropharmacology; 2004 Aug 17; 47 Suppl 1():14-23. PubMed ID: 15464122 [Abstract] [Full Text] [Related]
20. In vivo stimulation of D1 receptors increases the phosphorylation of proteins in the striatum. Lewis RM, Levari I, Ihrig B, Zigmond MJ. J Neurochem; 1990 Sep 17; 55(3):1071-4. PubMed ID: 2166772 [Abstract] [Full Text] [Related] Page: [Next] [New Search]